Osteoblasts contribute to a protective niche that supports melanoma cell proliferation and survival.

Abstract

Melanoma is the deadliest form of skin cancer; a primary driver of this high level of morbidity is the propensity of melanoma cells to metastasize. When malignant tumours develop distant metastatic lesions the new local tissue niche is known to impact on the biology of the cancer cells. However, little is known about how different metastatic tissue sites impact on frontline targeted therapies. Intriguingly, melanoma bone lesions have significantly lower response to BRAF or MEK inhibitor therapies. Here, we have investigated how the cellular niche of the bone can support melanoma cells by stimulating growth and survival via paracrine signalling between osteoblasts and cancer cells. Melanoma cells can enhance the differentiation of osteoblasts leading to increased production of secreted ligands, including RANKL. Differentiated osteoblasts in turn can support melanoma cell proliferation and survival via the secretion of RANKL that elevates the levels of the transcription factor MITF, even in the presence of BRAF inhibitor. By blocking RANKL signalling, either via neutralizing antibodies, genetic alterations or the RANKL receptor inhibitor SPD304, the survival advantage provided by osteoblasts could be overcome.

• Authors: Jennifer Ferguson, Daniel J Wilcock, Sophie McEntegart, Andrew P Badrock, Mitch Levesque, Reinhard Dummer, Claudia Wellbrock, Michael P Smith
• Journal: Pigment cell & melanoma research (Pigment Cell Melanoma Res) Vol. 33 Issue 1 Pg. 74-85 (01 2020) ISSN: 1755-148X [Electronic] England
• PMID: 31323160 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
• Copyright: © 2019 The Authors. Pigment Cell & Melanoma Research published by John Wiley & Sons Ltd.

Chemical References

• Microphthalmia-Associated Transcription Factor
• RANK Ligand
• Proto-Oncogene Proteins B-raf

Topics

• Cell Differentiation
• Cell Line, Tumor
• Cell Proliferation
• Cell Survival
• Gene Expression Regulation, Neoplastic
• Humans
• Melanoma (genetics, pathology)
• Microphthalmia-Associated Transcription Factor (genetics, metabolism)
• Osteoblasts (pathology)
• Proto-Oncogene Proteins B-raf (antagonists & inhibitors, metabolism)
• RANK Ligand (metabolism)
• Signal Transduction